Lithocholic Acid Derivatives as Potent Vitamin D Receptor Agonists
Lithocholic acid ( ) was identified as a second endogenous ligand of vitamin D receptor (VDR), though its activity is very weak. In this study, we designed novel lithocholic acid derivatives based on the crystal structure of VDR-ligand-binding domain (LBD) bound to . Among the synthesized compounds,...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2021-01, Vol.64 (1), p.516-526 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Lithocholic acid (
) was identified as a second endogenous ligand of vitamin D receptor (VDR), though its activity is very weak. In this study, we designed novel lithocholic acid derivatives based on the crystal structure of VDR-ligand-binding domain (LBD) bound to
. Among the synthesized compounds,
bearing a 2-hydroxy-2-methylprop-1-yl group instead of the 3-hydroxy group at the 3α-position of
showed dramatically increased activity in HL-60 cell differentiation assay, being at least 10 000 times more potent than lithocholic acid (
) and 3 times more potent than 1α,25-dihydroxyvitamin D
(
). Although the binding affinities of
and its epimer
were less than that of
, their transactivation activities were greater than that of
. X-ray structure analyses of VDR LBD bound to
or
showed that the binding positions of these compounds in the ligand-binding pocket are similar to that of
. |
---|---|
ISSN: | 0022-2623 1520-4804 |
DOI: | 10.1021/acs.jmedchem.0c01420 |